Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma
NCT06927128
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
UTUC
NAC
Interventions
DRUG:
Gemcitabine, Cisplatin
Sponsor
Changhai Hospital